Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.54 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.54 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | PGR | P06401 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | AR | P10275 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28450063 | 0.94 | ESR1 (0.48) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL22528987 | 0.88 | ESR1 (0.48) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL8760147 | 0.87 | ESR2 (0.52) | ESR1ESR2PDCD1CD274CYP3A4 | |
| SCHEMBL9329668 | 0.86 | ESR1 (0.54) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL1596715 | 0.85 | ESR1 (0.50) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL859331 | 0.84 | ESR1 (0.57) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL109016 | 0.84 | ESR1 (0.52) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL8760964 | 0.84 | LTA4H (0.58) | TDP1LMNACYP1A2MAPTPTGS1 | |
| SCHEMBL8760947 | 0.82 | ESR1 (0.42) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL6327533 | 0.82 | TAAR1 (0.52) | ESR1ESR2PDCD1CD274CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 752 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9939747-B2 | Developing agent and method for producing the same | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2018-04-10 | — | — | US | claimed |
| US-20170038698-A1 | DEVELOPING AGENT AND METHOD FOR PRODUCING THE SAME | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2017-02-09 | — | — | US | claimed |
| JP-2010513057-A | — | — | 2010-04-30 | — | — | JP | claimed |
| EP-2091731-A1 | PREPREG LAMINATES | Henkel Corporation (US) | 2009-08-26 | — | — | EP | claimed |
| US-7560143-B2 | Aqueous non-ionically stabilized epoxy resins | SURFACE SPECIALTIES AUSTRIA GMBH (AT) | 2009-07-14 | — | — | US | claimed |
| JP-2009518465-A | — | — | 2009-05-07 | — | — | JP | claimed |
| EP-1954759-A1 | CURABLE COMPOSITIONS | Henkel Corporation (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2008076244-A1 | PREPREG LAMINATES | HENKEL CORPORATION (US) | 2008-06-26 | — | — | WO | claimed |
| WO-2007064801-A1 | CURABLE COMPOSITIONS | HENKEL CORPORATION (US) | 2007-06-07 | — | — | WO | claimed |
| EP-1470181-B1 | IMPROVED INTERFACE ADHESIVE | LORD CORP (US) | 2005-08-24 | — | — | EP | claimed |
| US-6888257-B2 | Useful for integrated circuit packages enabling conducting heat generated by the die | LORD CORPORATION (US) | 2005-05-03 | — | — | US | claimed |
| EP-1470181-A1 | IMPROVED INTERFACE ADHESIVE | Lord Corporation (US) | 2004-10-27 | — | — | EP | claimed |
| WO-2004003066-A1 | IMPROVED INTERFACE ADHESIVE | LORD CORPORATION (US) | 2004-01-08 | — | — | WO | claimed |
| US-20040000712-A1 | Interface adhesive | LORD CORPORATION | 2004-01-01 | — | — | US | claimed |
| US-20020117259-A1 | Two part, room temperature curable epoxy resin/ (meth) acrylate compositions with high flash point and low odor, reaction products of which demonstrate improved fixture | Henkel IP & Holding GmbH (DE) | 2002-08-29 | — | — | US | claimed |
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | THE PILOT INK CO., LTD. (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-3954745-B1 | REVERSIBLY THERMOCHROMIC AQUEOUS INK COMPOSITION FOR WRITING UTENSILS, AND REFILL AND WATER-BASED BALLPOINT PEN EACH INTERNALLY CONTAINING SAME | KK PILOT CORPORATION ALSO TRADING AS PILOT CORPORATION (JP) | 2026-01-07 | — | — | EP | disclosed |
| US-4469861-A | Polycarbonate composition from branched chain dihydric phenol | GENERAL ELECTRIC COMPANY (US) | 1984-09-04 | — | — | US | disclosed |
| US-4463161-A | Polyarylate compositions | GENERAL ELECTRIC COMPANY (US) | 1984-07-31 | — | — | US | disclosed |
| EP-0112530-A2 | Polycarbonate compositions | GENERAL ELECTRIC COMPANY (US) | 1984-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | TYR, SCO2, HBB | ESR1 4366/4885ESR2 3067/4885PDCD1 4031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.